Baillie Gifford - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$8,083,098
+0.1%
86,321
-4.6%
0.01%0.0%
Q2 2023$8,077,303
-17.8%
90,502
-1.3%
0.01%
-22.2%
Q1 2023$9,831,324
-12.2%
91,693
+0.0%
0.01%
-25.0%
Q4 2022$11,197,122
+22.5%
91,682
+3.6%
0.01%
+33.3%
Q3 2022$9,139,000
+14.6%
88,497
+3.1%
0.01%
+12.5%
Q2 2022$7,976,000
-28.2%
85,800
-9.4%
0.01%0.0%
Q1 2022$11,108,000
-4.1%
94,651
+10.0%
0.01%
+33.3%
Q4 2021$11,580,000
-12.9%
86,072
+3.2%
0.01%
-14.3%
Q3 2021$13,299,000
+35.6%
83,434
+11.9%
0.01%
+40.0%
Q2 2021$9,807,000
-25.6%
74,552
-27.1%
0.01%
-28.6%
Q1 2021$13,183,000
+67.6%
102,294
+116.9%
0.01%
+75.0%
Q4 2020$7,865,00047,1550.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2023
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
View complete list of ASCENDIS PHARMA A/S shareholders